Infective endocarditis and outcomes of mitral valve replacement

Vesa Anttila1, Markus Malmberg1, Jarmo Gunn1

  • 1Heart Center, Turku University Hospital and University of Turku, Turku, Finland.

Abstract

Insights

Patients with native mitral valve infective endocarditis (IE) face higher mortality and bleeding risks after mitral valve replacement (MVR). Early complication prevention is crucial for improved outcomes in IE patients undergoing MVR.

Area of Science:

  • Cardiovascular Surgery
  • Infectious Diseases
  • Clinical Outcomes Research

Background:

  • Native mitral valve infective endocarditis (IE) poses significant challenges in cardiac surgery.
  • Understanding the long-term sequelae of mitral valve replacement (MVR) in IE patients is critical.

Purpose of the Study:

  • To evaluate the long-term outcomes of MVR in patients with native mitral valve IE.
  • To compare mortality, bleeding events, and other complications between IE and non-IE patients post-MVR.

Main Methods:

  • A multicentre, population-based cohort study included 1233 adult patients undergoing first-time MVR.
  • 170 patients had mitral valve IE; propensity score matching created 134 matched pairs.
  • Median follow-up was 6.1 years.

Main Results:

  • Pre-operative IE was linked to increased 10-year mortality (38.8% vs 30.5%) and higher major bleeding rates (26.0% vs 23.4%) after MVR.
  • IE patients experienced longer hospital admissions (28 vs 11 days).
  • Ischemic stroke and re-sternotomy rates were similar between groups.

Conclusions:

  • Native mitral valve IE significantly increases the risk of death and major bleeding post-MVR.
  • These findings underscore the necessity of proactive complication prevention strategies for IE patients undergoing MVR.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
74
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
121
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
115
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
71
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
128
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
130